About George Ng
George Ng is a chief executive officer and director at Processa Pharmaceuticals.
Form D filings name George Ng as a director at TuHURA Biosciences and Calidi Biotherapeutics.
George Ng reports to the SEC as a director or officer of 4 public companies, including TuHURA Biosciences (HURA), Calidi Biotherapeutics (CLDI) and Sorrento Therapeutics (SRNEQ).
George Ng first appears on SEC filings in 2015.
Experience
This experience comes from SEC filings. The years are when the filings name George Ng in the role, so the role may have started earlier or lasted longer.
PI
Processa Pharmaceuticals, Inc.
Chief Executive Officer and director
2023 – 2026 · Public company (PCSA)
SI
Sorrento Therapeutics, Inc.
Officer
2015 – 2018 · Public company (SRNEQ)
Key Colleagues at Startups
The people George Ng works with at each company, as listed on that company's latest Form D.
TuHURA Biosciences, Inc. · Form D, Dec 27, 2023
PL
Patricia Lawman
Director
DD
Dan Dearborn
Chief Financial Officer
AL
Alan List
Director
JB
James Bianco
Executive officer and director
JM
James Manuso
Director
KP
Kiran Patel
Director
ML
Michael Lawman
Director
Calidi Biotherapeutics, Inc. · Form D, Jun 29, 2023
AC
Allan Camaisa
CEO and director
HL
Heehyoung Lee
Director
JS
James Schoeneck
Director
AZ
Alfonso Zulueta
Director
AS
Anthony Santidrian
Executive officer
BM
Boris Minev
Interim Chief Medical Officer
ST
Stephen Thesing
Chief Business Officer
TK
Tony Kalajian
Interim Chief Financial Officer
AP
Amish Patel
Vice President of Technical Operations
DS
David Sans
Chief of Corporate Development
WP
Wendy Pizarro
Executive officer
SL
Scott Leftwich
Director